A Longitudinal Study of the Factor VII Rise during Pregnancy

Summary

A longitudinal study of 21 pregnant women has been undertaken using a variety of factor VII assays, including factor VIIa, to investigate the increase of factor VIIc. All assays demonstrated significant rises (p <0.001), most marked for factor VIIa (82%) and factor VIIc rabbit (81%). Smaller rises were seen for factor VIIc bovine (50%) and VII antigen (40%). Three indirect measures of activity state, factor VIIc rabbit:antigen, bovine:antigen and bovine:rabbit, provided conflicting data. Factor VIIa:antigen showed a significant increase of 36% (p <0.001). Within individual pregnancies the change in factor VIIc rabbit and antigen correlated with maternal weight gain (p <0.05). Two activity state measures, bovine:rabbit and bovine:antigen, showed negative correlation with birthweight. The increases in both zymogen and in activity state appear to contribute to the factor VIIc rise. The extent of this rise appears to be influenced by maternal weight gain. Increased factor VII activation is associated with reduced foetal growth.

• References

• 1 Loeliger EA, Koller F. Behaviour of factor VII and prothrombin in late pregnancy and in the newborn. Acta Haematol 1952; 7: 157-61.
• 2 Dalaker K. Clotting factor VII during pregnancy, delivery and puerperium. Brit Journal Obs and Gynaecol 1986; 93: 17-21.
• 3 Morrissey JH, Malik BG, Neuenschuander PF, Camp PC. Quantitations of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
• 4 Mitropoulos KA. Hypercoagulability and factor VII in hypertriglyceridaemia. Semin. Thromb Haemost 1988; 14: 246-52.
• 5 Hubbard AR, Parr LJ, Bains MG. Pregnancy and factor VII. Brit J Haemat 1992; 80: 265-6.
• 6 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemost 1992; 68: 301-5.
• 7 Hemker HC, Muller AD, Gonggrijp R. The estimation of activated human blood coagulation factor VII. J Mol Med 1976; 1: 127-34.
• 8 Biggs R, MacFarlane RG. Human blood coagulation. 3rd Edition. Blackwell Scientific Publications; Oxford: 1962
• 9 Cerskus AL, Ofosu FA, Birchall KJ. et al. The immunodepletion of factor VII from human plasma using a monoclonal antibody. Brit J Haemat 1985; 61: 467-75.
• 10 Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in Normal Pregnancy. Thromb Haemost 1984; 52: 176-82.
• 11 Mitropoulos KA, Martin JC, Stirling Y, Morrissey JH, Cooper JA. Activation of factor VII induced in citrated plasma in the presence of covalent surface. Thromb Res 1995; 78: 67-75.
• 12 Balleisen L, Bailey J, Epping P-H, Schulte H, Van de Loo J. Epidemiological study on factor VII, factor VII and fibrinogen in an industrial population: I Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemost 1985; 54: 475-9.
• 13 Warth MR, Arky RA, Knopp RH. Lipid metabolism in pregnancy, III. Altered lipid composition in intermediate, very low, low and high-density lipoprotein fractions. J Clin Endocrinol Metab 1975; 41: 649-55.
• 14 Carvalho De Sousa J, Bruckert E, Giral P. et al. Coagulation factor VII and plasma triglycerides. Haemostasis 1989; 19: 125-30.
• 15 Scarabin PY, Bonithon-Kopp C, Bara L, Samama M, Blot P. Is factor VII activation in pregnant women relevant to foetal growth retardation?. Thromb Res 1987; 45: 845-50.
• 16 Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and foetal growth retardation. Brit J Obst Gyn 1981; 88: 695-705.
• 17 Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 2: 577-80.